Cantor Fitzgerald Starts Immunogen Inc. (IMGN) at Hold, $15 Target

Article Stock Quotes (1) Comments (0)

Cantor Fitzgerald initiated coverage on Immunogen Inc. (NASDAQ: IMGN) with a Hold rating and a $15 price target Wednesday afternoon.

The firm said the company "is approaching commercial revenue via a partnership with Roche, and this is a solid positive for the stock. However, much of the good news is in the valuation and another catalyst is needed for greater appreciation..."

For an analyst ratings summary and ratings history on Immunogen Inc. click here. For more ratings news on Immunogen Inc. click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
• Topeka Capital Starts Atmel (ATML) at Buy
• Janney Capital Trims Numbers on Buckle (BKE), Margins Peaking

Create E-mail Alert Related Categories

New Coverage

Related Entities

Cantor Fitzgerald

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?